Transporter-mediated drug delivery: recent progress and experimental approaches (Q35876594)

10 August 2017

1 reference

title

Transporter-mediated drug delivery: recent progress and experimental approaches (English)

1 reference

10 August 2017

1 reference

Yoshimichi Sai

1

1 reference

10 August 2017

Akira Tsuji

series ordinal

2

1 reference

10 August 2017

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

9

1 reference

10 August 2017

issue

16

1 reference

10 August 2017

page(s)

712-720

1 reference

Tissue selective drug delivery utilizing carrier-mediated transport systems

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Proton-cotransport of pravastatin across intestinal brush-border membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Grapefruit juice activates P-glycoprotein-mediated drug transport

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Transporter-mediated permeation of drugs across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Carrier-mediated transport of H1-antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Pharmacological study of ebastine, a novel histamine H1-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Carrier-mediated intestinal transport of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Impact of drug transporter studies on drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

The intestinal H+/peptide symporter PEPT1: structure-affinity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Function and molecular structure of brush border membrane peptide/H+ symporters

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Expression cloning of a mammalian proton-coupled oligopeptide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Interaction of beta-lactam antibiotics with histidine residue of rat H+/peptide cotransporters, PEPT1 and PEPT2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Peptide mimics as substrates for the intestinal peptide transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Mechanism of absorption of the dipeptide alpha-methyldopa-phe in intestinal brush-border membrane vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Targeted prodrug design to optimize drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

The superfamily of organic anion transporting polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Transport of amino acid-based prodrugs by the Na+- and Cl(-) -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Transport of D-serine via the amino acid transporter ATB(0,+) expressed in the colon

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Na+ - and Cl- -coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B(0,+)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Cancer cell-targeted drug delivery utilizing oligopeptide transport activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Functional expression of novel peptide transporter in renal basolateral membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Uptake of dipeptide and beta-lactam antibiotics by the basolateral membrane vesicles prepared from rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Delivery of peptide drugs to the brain by adenovirus-mediated heterologous expression of human oligopeptide transporter at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Differential activity of bcl-2 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Structure-activity relationship of P-glycoprotein substrates and modifiers.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Transporter-mediated Drug Interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

The genetic polymorphism of drug transporters: functional analysis approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903198-8

7 January 2021

10.1016/S1359-6446(04)03198-8

Identifiers

DOI

1 reference

10 August 2017

1 reference